LORD, ABBETT & CO. LLC - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 165 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2018. The put-call ratio across all filers is 1.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
LORD, ABBETT & CO. LLC ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q2 2022$19,373,000
-15.0%
324,724
+3.5%
0.07%
+11.5%
Q1 2022$22,784,000
-13.6%
313,744
+0.0%
0.06%
+1.7%
Q4 2021$26,378,000
-32.0%
313,681
-27.0%
0.06%
-35.5%
Q3 2021$38,773,000
+11.5%
429,906
+17.8%
0.09%
+10.7%
Q2 2021$34,784,000
-19.1%
364,809
-3.4%
0.08%
-23.6%
Q1 2021$43,019,000
+106.1%
377,826
+38.2%
0.11%
+89.7%
Q3 2018$20,877,000
+87.2%
273,479
+74.0%
0.06%
+70.6%
Q3 2016$11,150,000
-32.4%
157,176
-53.4%
0.03%
-34.6%
Q2 2016$16,490,000
+67.1%
337,153
+116.3%
0.05%
+67.7%
Q1 2016$9,869,000
-68.5%
155,883
-44.3%
0.03%
-67.0%
Q4 2015$31,378,000
+40.7%
279,713
+20.8%
0.09%
+40.3%
Q3 2015$22,303,000
-70.1%
231,580
-68.2%
0.07%
-65.8%
Q2 2015$74,505,000
+91.0%
727,659
+15.8%
0.20%
+98.0%
Q1 2015$39,013,000
+108.0%
628,332
+47.0%
0.10%
+106.2%
Q4 2014$18,755,000
-42.6%
427,416
-26.0%
0.05%
-41.5%
Q3 2014$32,694,000
+57.1%
577,631
+24.6%
0.08%
+241.7%
Q2 2014$20,816,000
+686.4%
463,732
+756.5%
0.02%
+300.0%
Q1 2014$2,647,00054,1440.01%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q4 2018
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 727,426$25,932,7374.72%
RTW INVESTMENTS, LP 5,405,089$192,691,4234.07%
First Light Asset Management, LLC 1,125,032$40,107,3913.81%
CHI Advisors LLC 215,000$7,664,7503.04%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 250,052$8,914,3543.00%
SPHERA FUNDS MANAGEMENT LTD. 259,135$9,238,1631.68%
Rock Springs Capital Management LP 1,476,441$52,635,1221.41%
SUVRETTA CAPITAL MANAGEMENT, LLC 679,459$24,222,7131.31%
Privium Fund Management B.V. 115,241$4,108,3411.22%
SECTOR GAMMA AS 115,166$4,105,6681.05%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders